首页> 外文期刊>Analytical and Bioanalytical Chemistry >Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer
【24h】

Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer

机译:通过台式四极杆/ Orbitrap质谱仪灵敏地确定用于掺杂控制的干血斑(DBS)中的违禁药物

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, a new type of mass spectrometer combining a quadrupole mass filter, a higher collision dissociation (HCD) cell and an Orbitrap detector, was evaluated for the analysis of dried blood spots (DBS) in doping controls. DBS analysis is characterized by the necessity to detect prohibited compounds in sub-nanogram-per-milliliter levels with high identification capacity. After extraction of DBS with an organic solvent and liquid chromatographic separation (using a regular C18-RP-analytical UHPLC-column) of target analytes, mass spectrometry is performed with a high-resolution full scan in positive and negative mode by means of electrospray ionisation. Single-product ion mass spectra are acquired using the data-dependent analysis mode (employing an inclusion list) for previously selected precursors of known prohibited compounds with fixed retention time ranges. Besides, a sensitive screening in a targeted approach, non-targeted analysis for retrospective data evaluation is thus possible. The chosen experimental design enables the determination of various drugs from different classes with one generic sample preparation which is shown for 26 selected model compounds (Δ9-tetrahydrocannabinol (THC), tetrahydrocannabinol-9-carboxylic acid (THC-COOH), methylhexaneamine, methylphenidate, cocaine, nikethamide, 3,4-methylenedioxyamphetamine, N-methyl-3,4-methylenedioxyamphetamine, strychnine, mesocarb, salbutamol, formoterol, clenbuterol, metandienone, stanozolol, bisoprolol, propranolol, metoprolol, anastrazole, clomiphene, exemestane, dexamethasone, budesonide, selective androgen receptor modulator (SARM) S4 (andarine), SARM S1, hydrochlorothiazide). Generally, only qualitative result interpretation was focussed upon, but for target analytes with deuterium-labelled internal standards (salbutamol, clenbuterol, cocaine, dexamethasone, THC-COOH and THC) quantitative analysis was also possible. Especially the most challenging analytes, THC and its carboxy metabolite, were detected in DBS at relevant concentrations (<0.5 ng/mL) using targeted HCD experiments. The method was validated for the parameters: specificity, linearity (0–20 ng/mL), precision (<25%), recovery (mean 60%), limit of detection/quantification, ion suppression, stability and accuracy (80–120%). Six isotope-labelled analogues used as internal standards facilitate a quantitative result interpretation which is of utmost importance especially for in-competition drug sports testing.
机译:在本研究中,评估了一种新型质谱仪,该质谱仪结合了四极质量过滤器,更高的碰撞解离(HCD)细胞和Orbitrap检测器,用于分析兴奋剂对照中的干血斑(DBS)。 DBS分析的特点是必须以高识别能力检测出每毫微纳克以下的禁用化合物。在用有机溶剂萃取DBS并进行目标分析物液相色谱分离(使用常规C18-RP分析型UHPLC色谱柱)后,通过电喷雾电离以正负模式进行高分辨率全扫描进行质谱分析。使用数据依赖的分析模式(采用包含物列表)获取具有固定保留时间范围的已知禁用化合物的先前选择的前体,从而获得单产品离子质谱图。除此之外,有针对性地进行有针对性的筛选,非目标性分析以进行回顾性数据评估是可能的。所选的实验设计可通过一种通用的样品制备方法测定不同类别的各种药物,该样品制备方法可显示26种所选模型化合物(Δ 9 -四氢大麻酚(THC),四氢大麻酚-9-羧酸(THC -COOH),甲基己胺,哌醋甲酯,可卡因,尼克乙酰胺,3,4-亚甲基二氧苯丙胺,N-甲基-3,4-亚甲基二氧苯丙胺,士的宁,美索威,沙丁胺醇,福莫特罗,盐酸克伦特罗,美丹宁酮,斯坦唑醇,比索洛尔,普萘洛尔,美托洛尔,美托洛尔克罗米芬,依西美坦,地塞米松,布地奈德,选择性雄激素受体调节剂(SARM)S4(黄嘌呤),SARM S1,氢氯噻嗪)。通常,只着重于定性结果的解释,但对于具有氘标记内标(沙丁胺醇,盐酸克伦特罗,可卡因,地塞米松,THC-COOH和THC)的目标分析物,也可以进行定量分析。使用靶向HCD实验,尤其是在DBS中以相关浓度(<0.5 ng / mL)检测到最具挑战性的分析物THC及其羧基代谢物。验证了该方法的参数:特异性,线性(0–20 ng / mL),精密度(<25%),回收率(平均60%),检测/定量限,离子抑制,稳定性和准确性(80–120) %)。六种同位素标记的类似物用作内标,有助于定量结果的解释,这尤其对于竞争中的药物运动测试至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号